Gene Expression Profiling Reveals Epithelial Mesenchymal Transition (EMT) Genes Can Selectively Differentiate Eribulin Sensitive Breast Cancer Cells

Zoltán Dezső; Judith Oestreicher; Amy Weaver; Stephanie Santiago; Sergei Agoulnik; Jesse Chow; Yoshiya Oda; Yasuhiro Funahashi

doi:10.1371/journal.pone.0106131

Loading metrics

Open Access

Peer-reviewed

Research Article

Gene Expression Profiling Reveals Epithelial Mesenchymal Transition (EMT) Genes Can Selectively Differentiate Eribulin Sensitive Breast Cancer Cells

Zoltán Dezső,

Affiliation Biomarkers and Personalized Medicine Core Function Unit, Eisai Product Creation Systems, Eisai Inc., Andover, Massachusetts, United States of America
⨯
Judith Oestreicher,

Current address: Infinity Pharmaceuticals, Cambridge, Massachusetts, United States of America

Affiliation Biomarkers and Personalized Medicine Core Function Unit, Eisai Product Creation Systems, Eisai Inc., Andover, Massachusetts, United States of America
⨯
Amy Weaver,

Affiliation Biomarkers and Personalized Medicine Core Function Unit, Eisai Product Creation Systems, Eisai Inc., Andover, Massachusetts, United States of America
⨯
Stephanie Santiago,

Affiliation Biomarkers and Personalized Medicine Core Function Unit, Eisai Product Creation Systems, Eisai Inc., Andover, Massachusetts, United States of America
⨯
Sergei Agoulnik,

Affiliation Biomarkers and Personalized Medicine Core Function Unit, Eisai Product Creation Systems, Eisai Inc., Andover, Massachusetts, United States of America
⨯
Jesse Chow,

Affiliation Biomarkers and Personalized Medicine Core Function Unit, Eisai Product Creation Systems, Eisai Inc., Andover, Massachusetts, United States of America
⨯
Yoshiya Oda,

Affiliation Biomarkers and Personalized Medicine Core Function Unit, Eisai Product Creation Systems, Eisai Inc., Andover, Massachusetts, United States of America
⨯
Yasuhiro Funahashi

* E-mail: Yasuhiro_Funahashi@eisai.com

Affiliation Biomarkers and Personalized Medicine Core Function Unit, Eisai Product Creation Systems, Eisai Inc., Andover, Massachusetts, United States of America
⨯

Gene Expression Profiling Reveals Epithelial Mesenchymal Transition (EMT) Genes Can Selectively Differentiate Eribulin Sensitive Breast Cancer Cells

Zoltán Dezső,
Judith Oestreicher,
Amy Weaver,
Stephanie Santiago,
Sergei Agoulnik,
Jesse Chow,
Yoshiya Oda,
Yasuhiro Funahashi

Published: August 29, 2014
https://doi.org/10.1371/journal.pone.0106131

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Uterine cancer
Is the Subject Area "Uterine cancer" applicable to this article?

Thanks for your feedback.
Ovarian cancer
Is the Subject Area "Ovarian cancer" applicable to this article?

Thanks for your feedback.
Gene expression
Is the Subject Area "Gene expression" applicable to this article?

Thanks for your feedback.
Tubulins
Is the Subject Area "Tubulins" applicable to this article?

Thanks for your feedback.
Cytoskeleton
Is the Subject Area "Cytoskeleton" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.